Moderna seeks FDA clearance for COVID-19 vaccine in young children
The biotech’s shot would become the first available to children under 6, the last remaining age group currently ineligible for vaccination.
The biotech’s shot would become the first available to children under 6, the last remaining age group currently ineligible for vaccination.